Medicalgorithmics S.A. (WSE:MDG)
Poland · Delayed Price · Currency is PLN 32.35
-0.50 (-1.52%)
Feb 27, 2026, 5:00 PM CET
Medicalgorithmics Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 26.8 | 24 | 43.1 | 62.72 | 48.35 | 111.73 | |
Revenue Growth (YoY) | -12.64% | -44.31% | -31.28% | 29.72% | -56.73% | -35.74% |
Cost of Revenue | 17.86 | 22.44 | 26.12 | 29.52 | 22.84 | 100.44 |
Gross Profit | 8.94 | 1.57 | 16.98 | 33.2 | 25.51 | 11.29 |
Selling, General & Admin | 17.56 | 15.67 | 13.39 | 12.22 | 8.7 | 29.88 |
Other Operating Expenses | 2.2 | -0.64 | 1.51 | 1.01 | 0.53 | 3.98 |
Operating Expenses | 24.02 | 18.67 | 17.26 | 17.24 | 13.41 | 49.75 |
Operating Income | -15.08 | -17.1 | -0.28 | 15.96 | 12.1 | -38.46 |
Interest Expense | -1.4 | -0.16 | -0.11 | -0.27 | -0.61 | -0.96 |
Interest & Investment Income | 0.02 | 0.23 | 0.75 | - | 0.24 | 0.18 |
Currency Exchange Gain (Loss) | 0.59 | 0.48 | -1.35 | 8.08 | 2.9 | -1.6 |
Other Non Operating Income (Expenses) | 0.18 | 0.22 | 0.04 | 0.24 | 0.11 | -0.06 |
EBT Excluding Unusual Items | -15.68 | -16.34 | -0.95 | 24.01 | 14.73 | -40.9 |
Gain (Loss) on Sale of Investments | 2.62 | 2.62 | - | - | - | - |
Asset Writedown | -2.06 | -2.06 | 0.71 | - | -21.74 | -3.11 |
Other Unusual Items | - | - | - | 1.26 | - | 4.06 |
Pretax Income | -15.12 | -15.78 | -0.24 | 25.26 | -7.01 | -39.95 |
Income Tax Expense | 0.25 | 0.3 | 0.34 | -0.22 | -0.44 | -12.27 |
Earnings From Continuing Operations | -15.38 | -16.08 | -0.58 | 25.48 | -6.57 | -27.68 |
Earnings From Discontinued Operations | - | - | - | -37.34 | -174.07 | - |
Net Income to Company | -15.38 | -16.08 | -0.58 | -11.86 | -180.64 | -27.68 |
Minority Interest in Earnings | -0.01 | -0 | - | - | - | 14.76 |
Net Income | -15.38 | -16.08 | -0.58 | -11.86 | -180.64 | -12.92 |
Net Income to Common | -15.38 | -16.08 | -0.58 | -11.86 | -180.64 | -12.92 |
Shares Outstanding (Basic) | 10 | 10 | 10 | 6 | 5 | 4 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 6 | 5 | 4 |
Shares Change (YoY) | - | - | 74.58% | 25.38% | 9.88% | 14.72% |
EPS (Basic) | -1.55 | -1.62 | -0.06 | -2.08 | -39.73 | -3.12 |
EPS (Diluted) | -1.55 | -1.62 | -0.06 | -2.08 | -39.73 | -3.12 |
Free Cash Flow | -5.28 | -13.22 | -0.31 | 6.33 | -16.39 | -4.37 |
Free Cash Flow Per Share | -0.53 | -1.33 | -0.03 | 1.11 | -3.60 | -1.06 |
Gross Margin | 33.36% | 6.53% | 39.40% | 52.94% | 52.76% | 10.11% |
Operating Margin | -56.27% | -71.24% | -0.65% | 25.44% | 25.03% | -34.42% |
Profit Margin | -57.39% | -67.00% | -1.34% | -18.91% | -373.61% | -11.56% |
Free Cash Flow Margin | -19.69% | -55.07% | -0.71% | 10.09% | -33.90% | -3.91% |
EBITDA | -14.53 | -16.55 | 0.14 | 16.6 | 22.05 | -28.61 |
EBITDA Margin | -54.23% | -68.96% | 0.33% | 26.47% | 45.61% | -25.61% |
D&A For EBITDA | 0.55 | 0.55 | 0.42 | 0.64 | 9.95 | 9.85 |
EBIT | -15.08 | -17.1 | -0.28 | 15.96 | 12.1 | -38.46 |
EBIT Margin | -56.27% | -71.24% | -0.65% | 25.44% | 25.03% | -34.42% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.